Tara Bancroft
Stock Analyst at TD Cowen
(2.53)
# 1,365
Out of 4,667 analysts
8
Total ratings
40%
Success rate
25.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
TGTX TG Therapeutics | Initiates: Buy | $50 | $33.94 | +47.32% | 1 | Oct 29, 2024 | |
PTGX Protagonist Therapeutics | Initiates: Buy | $65 | $41.81 | +55.47% | 1 | Sep 24, 2024 | |
OCUL Ocular Therapeutix | Upgrades: Buy | $7 → $11 | $8.55 | +28.65% | 3 | Jun 20, 2024 | |
GERN Geron | Initiates: Buy | $10 | $4.02 | +149.07% | 1 | Apr 29, 2024 | |
MRUS Merus | Initiates: Outperform | n/a | $43.91 | - | 1 | Aug 21, 2023 | |
BCYC Bicycle Therapeutics | Initiates: Outperform | n/a | $20.01 | - | 1 | Aug 31, 2022 |
TG Therapeutics
Oct 29, 2024
Initiates: Buy
Price Target: $50
Current: $33.94
Upside: +47.32%
Protagonist Therapeutics
Sep 24, 2024
Initiates: Buy
Price Target: $65
Current: $41.81
Upside: +55.47%
Ocular Therapeutix
Jun 20, 2024
Upgrades: Buy
Price Target: $7 → $11
Current: $8.55
Upside: +28.65%
Geron
Apr 29, 2024
Initiates: Buy
Price Target: $10
Current: $4.02
Upside: +149.07%
Merus
Aug 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $43.91
Upside: -
Bicycle Therapeutics
Aug 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $20.01
Upside: -